Mainz Biomed B.V.

NasdaqCM:MYNZ

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🩺 Medical Instruments

💊 Pharmaceuticals

Location

Germany

Market Cap

USD 8.01 M

Share Price

USD 1.75

Avg Daily Volume

157,596

Change (1 day)

-0.57%

Change (1 year)

-87.40%

Change (YTD)

-59.49%

Mainz Biomed B.V. EBITDA for the year ending December 31, 2024: USD -19.56 M

Mainz Biomed B.V. EBITDA is USD -19.56 M for the year ending December 31, 2024, a -21.80% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Mainz Biomed B.V. EBITDA for the year ending December 31, 2023 was USD -25.01 M, a -2.75% change year over year.
Mainz Biomed B.V. EBITDA for the year ending December 31, 2022 was USD -25.72 M.
Mainz Biomed B.V. EBITDA for the year ending December 31, 2020 was USD -257.64 K, a -63.30% change year over year.